APA (7th ed.) Citation

FR, A., Z, K., H, M., AM, A., T, S., MK, A., . . . MA, S. (2024). Dapagliflozin mitigates cellular stress and inflammation through PI3K/AKT pathway modulation in cardiomyocytes, aortic endothelial cells, and stem cell-derived β cells. Cardiovascular diabetology, 23(1), 388. https://doi.org/10.1186/s12933-024-02481-y

Chicago Style (17th ed.) Citation

FR, Alsereidi, et al. "Dapagliflozin Mitigates Cellular Stress and Inflammation Through PI3K/AKT Pathway Modulation in Cardiomyocytes, Aortic Endothelial Cells, and Stem Cell-derived β Cells." Cardiovascular Diabetology 23, no. 1 (2024): 388. https://doi.org/10.1186/s12933-024-02481-y.

MLA (9th ed.) Citation

FR, Alsereidi, et al. "Dapagliflozin Mitigates Cellular Stress and Inflammation Through PI3K/AKT Pathway Modulation in Cardiomyocytes, Aortic Endothelial Cells, and Stem Cell-derived β Cells." Cardiovascular Diabetology, vol. 23, no. 1, 2024, p. 388, https://doi.org/10.1186/s12933-024-02481-y.